Advisory Board

The OncoFirm Diagnostics Advisory Board is composed of leading experts in oncology, molecular diagnostics, regulatory affairs, clinical medicine, and biotechnology commercialization. This distinguished group provides strategic guidance and scientific oversight as we advance the development and global deployment of our rapid cancer screening technologies.

Our advisors bring deep experience from academia, healthcare systems, diagnostic innovation, and public health policy—ensuring that our products are clinically relevant, regulatory-ready, and impactful across diverse healthcare settings. With their insights, we are driving innovation that empowers early cancer detection and improves outcomes for patients worldwide.